<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35320731</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1551</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Developmental cell</Title><ISOAbbreviation>Dev Cell</ISOAbbreviation></Journal><ArticleTitle>Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.</ArticleTitle><Pagination><StartPage>783</StartPage><EndPage>798.e8</EndPage><MedlinePgn>783-798.e8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.devcel.2022.02.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1534-5807(22)00124-1</ELocationID><Abstract><AbstractText>Fused in sarcoma (FUS) is a DNA/RNA-binding protein that is involved in DNA repair and RNA processing. FUS is associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the molecular mechanisms underlying FUS-mediated neurodegeneration are largely unknown. Here, using a Drosophila model, we showed that the overexpression of glutathione transferase omega 2 (GstO2) reduces cytoplasmic FUS aggregates and prevents neurodegenerative phenotypes, including neurotoxicity and mitochondrial dysfunction. We found a FUS glutathionylation site at the 447<sup>th</sup> cysteine residue in the RanBP2-type ZnF domain. The glutathionylation of FUS induces FUS aggregation by promoting phase separation. GstO2 reduced cytoplasmic FUS aggregation by deglutathionylation in Drosophila brains. Moreover, we demonstrated that the overexpression of human GSTO1, the homolog of Drosophila GstO2, attenuates FUS-induced neurotoxicity and cytoplasmic FUS accumulation in mouse neuronal cells. Thus, the modulation of FUS glutathionylation might be a promising therapeutic strategy for FUS-associated neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Sun Joo</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, Asan 31538, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seongsoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gwangju Center, Korea Basic Science Institute (KBSI), Gwangju 61186, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hyun-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Soonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan 31151, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yeo Jeong</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, Asan 31538, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Yu-Mi</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41068, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Myungjin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41068, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shinrye</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41068, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahm</LastName><ForeName>Minyeop</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41068, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Su Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, Hanyang University, Seoul 04763, Korea; Medical Research Institute, Hanyang University, Seoul 04763, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, Hanyang University, Seoul 04763, Korea; Medical Research Institute, Hanyang University, Seoul 04763, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41068, Korea. Electronic address: kijang1@kbri.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kiyoung</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, Asan 31538, Korea. Electronic address: kiyoung2@sch.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dev Cell</MedlineTA><NlmUniqueID>101120028</NlmUniqueID><ISSNLinking>1534-5807</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">fused in sarcoma</Keyword><Keyword MajorTopicYN="N">glutathione transferase omega</Keyword><Keyword MajorTopicYN="N">glutathionylation</Keyword><Keyword MajorTopicYN="N">liquid-liquid phase separation</Keyword><Keyword MajorTopicYN="N">post-translational modification</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>20</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35320731</ArticleId><ArticleId IdType="doi">10.1016/j.devcel.2022.02.022</ArticleId><ArticleId IdType="pii">S1534-5807(22)00124-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>